BRIEF: Novosense slips in Hong Kong trading debut

2676.HK
688052.SHG

Shares of analog integrated circuit (IC) maker Suzhou Novosense Microelectronics Co. Ltd. (688052.SH; 2676.HK) opened flat in their Hong Kong trading debut on Monday, then slipped in the morning to close down 6.64% at HK$108.30 by the midday break.

The company said it issued 19 million Hong Kong-listed shares priced at HK$116 each, representing the top of their range, raising net proceeds of HK$2.1 billion ($296 million). The Hong Kong tranche of the listing for local investors was 24.33 times oversubscribed, while the international offering was 1.65 times covered.

Novosense develops and sells high-performance analog and mixed-signal ICs for sensors, signal-chain and power-management chip systems. The company uses a fabless business model, concentrating on design and marketing, while outsourcing chip-making and testing to foundries.

For the first half of the year, Novosense reported revenue of 1.52 billion yuan, up 79.4% year-on-year. Its net loss narrowed to 78.01 million yuan from a loss of 256 million yuan in the same period last year.

By Lee Shih Ta

To subscribe to Bamboo Works weekly free newsletter, click here

, ,
, , , , ,

Related Articles

RELATED ARTICLES

  1. Dongshan makes PCBs
    Dongshan Precision offers investors an acquisitive, but debt heavy, tech component play 
    002384.SHE
  2. WUS Printed Circuit charges up Hong Kong’s growing tech pool
  3. Longsys nears Hong Kong listing with key regulatory green light
    301308.SHE
  4. BRIEF: Tianyu Semiconductor slides in Hong Kong trading debut
    2658.HK
  5. GigaDevice eyes Hong Kong IPO as internal and external challenges bite
    603986.SHG
  6. BRIEF: WeRide shares sink in Hong Kong trading debut
    0800.HK
    WRD.US
  7. BRIEF: Hipine surges in Hong Kong trading debut
    2583.HK
Discover hidden China stock gems in our weekly newsletter

Follow us

Facebook Twitter Linkedin Weixin Weibo Youtube

Subscribe to Our Free eNewsletter

Subscribe

Check out our content with some of our syndication partners

factiva

Recent Articles

Geneplus IPO

Geneplus locks onto targeted medicine for IPO pitch

After a post-Covid earnings dip, the company is seeking a stable future as a provider of data and diagnostics for precision medicine and disease prevention   Key Takeaways: The company’s…

Hong Kong’s IPO rally under scrutiny, as ZTE hits new U.S. headwinds

Hong Kong's stock regulator has warned IPO underwriters over the declining qualiy of new listing applications. Is this a red flag for the city's booming IPO market, or just the usual regulatory caution? And the U.S. could fine telecoms equipment maker ZTE $1 billion for bribery in Brazil. Why does Washington think it can force ZTE to pay such a large amount?